Centessa Pharmaceuticals (NASDAQ:CNTA) Sets New 12-Month High at $13.04
Centessa Pharmaceuticals plc (NASDAQ:CNTA – Get Free Report) reached a new 52-week high on Thursday . The stock traded as high as $13.04 and last traded at $13.02, with a volume of 185516 shares trading hands. The stock had previously closed at $12.60. Analyst Ratings Changes CNTA has been the subject of several research analyst […]
More Stories
Valence8 US LP Takes $268,000 Position in Intellia Therapeutics, Inc. (NASDAQ:NTLA)
Valence8 US LP bought a new position in Intellia Therapeutics, Inc. (NASDAQ:NTLA – Free Report) during the third quarter, Holdings...
Valence8 US LP Takes $268,000 Position in Intellia Therapeutics, Inc. (NASDAQ:NTLA)
Valence8 US LP bought a new position in Intellia Therapeutics, Inc. (NASDAQ:NTLA – Free Report) during the third quarter, Holdings...
Martin Marietta Materials, Inc. (NYSE:MLM) Stock Position Cut by Lathrop Investment Management Corp
Lathrop Investment Management Corp decreased its position in Martin Marietta Materials, Inc. (NYSE:MLM – Free Report) by 2.5% in the...
Martin Marietta Materials, Inc. (NYSE:MLM) Stock Position Cut by Lathrop Investment Management Corp
Lathrop Investment Management Corp decreased its position in Martin Marietta Materials, Inc. (NYSE:MLM – Free Report) by 2.5% in the...
AlphaCore Capital LLC Acquires 189 Shares of Blackstone Inc. (NYSE:BX)
AlphaCore Capital LLC increased its holdings in Blackstone Inc. (NYSE:BX – Free Report) by 1.6% in the 3rd quarter, according...
AlphaCore Capital LLC Acquires 189 Shares of Blackstone Inc. (NYSE:BX)
AlphaCore Capital LLC increased its holdings in Blackstone Inc. (NYSE:BX – Free Report) by 1.6% in the 3rd quarter, according...